Vital Therapies, Inc. News Headlines

VTL 
$18.01
*  
0.95
5.01%
Get VTL Alerts
*Delayed - data as of Oct. 2, 2014 11:06 ET  -  Find a broker to begin trading VTL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    VTL Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Ocera Therapeutics Finally Ready To Reward Investors
10/1/2014 12:32:00 PM - Seeking Alpha

Should You Get Rid of Vital Therapies (VTL) Now? - Tale of the Tape
9/17/2014 8:53:00 AM - Zacks.com

BDSI Hoping To Deliver, MDCO Gets FDA Nod, TXMD On Watch, Busy Days Await NVAX
8/7/2014 12:50:00 AM - RTT News

Monday Sector Laggards: Drugs, Education & Training Services
7/7/2014 2:29:29 PM - BNK Invest

Vital Therapies (VTL) Catches Eye: Stock Surges 20.7% - Tale of the Tape
6/12/2014 9:25:00 AM - Zacks.com

Vital Therapies Stands To Benefit From The High Unmet Need In Treating ALF Patients
5/29/2014 3:41:00 PM - Seeking Alpha

U.S. IPO Recap: The IPO Market Finds A Clearing Price
4/22/2014 12:31:00 PM - Seeking Alpha

Wednesday IPO Review & Sneak-Peek For Thursday, April 17
4/17/2014 6:39:00 AM - Investopedia

IPO Preview: Vital Therapies
4/17/2014 2:05:00 AM - Seeking Alpha

Vital Therapies prices IPO at $12, below the downwardly revised range
4/16/2014 5:47:21 PM - Renaissance Capital

11 U.S. IPOs Planned For The Week Of April 14
4/15/2014 9:00:00 AM - Seeking Alpha

Liver disease biotech Vital Therapies decreases range to $13 to $15
4/7/2014 8:56:50 AM - Renaissance Capital

Liver disease biotech Vital Therapies revives IPO filing, removes original terms
3/11/2014 9:18:23 AM - Renaissance Capital

Vital Therapies postpones $75 million IPO
11/21/2013 8:42:05 AM - Renaissance Capital

Liver disease biotech Vital Therapies sets terms for $75 million IPO
11/6/2013 9:05:28 AM - Renaissance Capital